百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

休市中 06-05 16:09:12

163.000

-4.900

-2.92%

最高170.600	最低161.100	成交量1,996万
今开169.200	昨收167.900	日振幅5.66%
总市值2,512亿	流通市值2,324亿	总股本15.41亿
成交额32.60亿	换手率1.40%	流通股本14.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":163,"timestamp":1780646952007,"preClose":167.9,"halted":0,"volume":19957783,"delay":0,"changeRate":-0.02918403811792737,"floatShares":1426000000,"shares":1541000000,"eps":1.4885032707900818,"marketStatus":"休市中","change":-4.9,"latestTime":"06-05 16:09:12","open":169.2,"high":170.6,"low":161.1,"amount":3260376293,"amplitude":0.056581,"askPrice":163,"askSize":860900,"bidPrice":162.9,"bidSize":9800,"shortable":3,"etf":0,"ttmEps":2.654064005640644,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":7,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":167.9,"openAndCloseTimeList":[[1780623000000,1780632000000],[1780635600000,1780646400000]],"volumeRatio":3.057760276426632,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":220.18,"timestamp":1780642800000,"preClose":223.98,"halted":0,"volume":3287000,"delay":0,"premium":"-35.92"},"impliedVol":0.3903,"impliedVolPercentile":0.3261},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2641122476","title":"每周股票复盘：百济神州（688235）股东Amgen持股比例被动稀释至16.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122476","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122476?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:36","pubTimestamp":1780767371,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘，百济神州报收于220.18元，较上周的243.9元下跌9.73%。本周，百济神州6月1日盘中最高价报248.88元。百济神州当前最新总市值3393.9亿元，在化学制药板块市值排名1/150，在两市A股市值排名40/5206。公司公告汇总百济神州有限公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","06160","688235","LU1303224171.USD","LU2328871848.SGD","LU0588546209.SGD","BK1500","LU1719994722.HKD","BK1583","LU1251922891.USD","LU0307460666.USD","BK1588","BK0239","LU1770034418.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2641829119","title":"百济神州(06160)：授出受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2641829119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641829119?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:12","pubTimestamp":1780650777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年6月1日，董事会薪酬委员会根据2016期权及激励计划的条款授予381名承授人合共42,648股美国存托股份受限制股份单位。该等受限制股份单位相当于554,424股股份，约占本公告之日公司发行股份总数的0.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","ONC","BK0239","688235","LU1303224171.USD","LU1770034418.SGD","BK1161","BK1500","LU1719994722.HKD","LU1969619763.USD","BK4585","LU0307460666.USD","BK4588","BK4526","LU1251922891.USD","LU2328871848.SGD","LU0588546209.SGD","BK1583","06160","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124035598","title":"异动解读｜百济神州盘中下跌3.1%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1124035598","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124035598?lang=zh_cn&edition=full","pubTime":"2026-06-05 13:34","pubTimestamp":1780637640,"startTime":"0","endTime":"0","summary":"6月5日，百济神州盘中下跌3.1%，报162.7港元/股，成交额5.42亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌3.92%、荣昌生物跌2.56%、三生制药跌1.81%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164340118","title":"百济神州5月无新增股份发行 股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1164340118","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164340118?lang=zh_cn&edition=full","pubTime":"2026-06-04 17:41","pubTimestamp":1780566089,"startTime":"0","endTime":"0","summary":"百济神州公布截至2026年5月31日的证券变动月报。公告显示，公司于该月未有新增发行股份或购回、注销及库藏股变动，已发行普通股数目维持在1,426,363,848股。公司于上海证券交易所科创板上市的115,055,260股人民币股份亦无变动。公司董事会确认，截至报告期末，已符合香港联交所防止持股过度集中的相关规则。公司表示将持续关注并严格遵守香港联交所及其他监管机构的相关规定，确保股本稳定及规范运作。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185489244","title":"异动解读｜百济神州盘中上涨4.18%，连续下跌后反弹叠加安泰适获批提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1185489244","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185489244?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:39","pubTimestamp":1780537162,"startTime":"0","endTime":"0","summary":"6月4日，百济神州盘中上涨4.18%，报171.2港元/股，成交额1.23亿港元。该股此前连续三个交易日累计下跌约10%，主要受Baker Bros. Advisors LP减持约1.9亿美元及创新药板块持续调整拖累。利好方面，百济神州5月29日宣布安泰适（注射用塔拉妥单抗）获NMPA批准用于广泛期小细胞肺癌二线治疗，临床数据显示可降低死亡风险40%，中位总生存期延长5.3个月。今日生物科技板块整体企稳，前期超跌个股出现反弹。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153099751","title":"异动解读｜百济神州盘中下跌3.02%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1153099751","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153099751?lang=zh_cn&edition=full","pubTime":"2026-06-03 10:37","pubTimestamp":1780454277,"startTime":"0","endTime":"0","summary":"6月3日，百济神州盘中下跌3.02%，报163.7港元/股，成交额2.9亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌4.6%、科伦博泰生物跌4.21%、三生制药跌3.32%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915411","title":"6月2日百济神州跌5.88%，万家行业优选LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915411","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915411?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389170,"startTime":"0","endTime":"0","summary":"证券之星消息，6月2日百济神州跌5.88%，收盘报220.82元，换手率4.99%，成交量5.75万手，成交额12.79亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共107家，其中持有数量最多的公募基金为万家基金的万家行业优选LOF。万家行业优选LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0307460666.USD","LU1969619763.USD","LU1251922891.USD","BK0239","06160","LU2328871848.SGD","BK1588","BK1161","BK1500","LU1303224171.USD","LU1719994722.HKD","BK1583","688235","160916","LU0588546209.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640915197","title":"百济神州跌5.88%，浦银国际证券二个月前给出“买入”评级，目标价236.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640915197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640915197?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:32","pubTimestamp":1780389156,"startTime":"0","endTime":"0","summary":"今日百济神州跌5.88%，收盘报220.82元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，研报发布时股价为238.49元，预期涨幅为1.04%。此外，东吴证券研究员朱国广，中邮证券研究员盛丽华,陈灿近期也对该股发布了研报，同样给出“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200030880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","06160","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106508512","title":"异动解读｜百济神州盘中下跌3.85%，高层减持叠加创新药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1106508512","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106508512?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:52","pubTimestamp":1780365134,"startTime":"0","endTime":"0","summary":"6月2日，百济神州盘中下跌3.85%，报165.8港元/股，成交额2.17亿港元。消息面上，百济神州近期遭遇贝克兄弟关联基金Baker Bros. Advisors LP大幅减持约1.9亿美元，虽其仍保留董事会席位且合计持股约8.21%，但减持动作持续压制市场情绪。此外，港股创新药板块自去年9月调整至今已超8个月，板块标的指数区间跌幅超30%。今日生物科技板块整体走弱，康方生物跌4.57%、三生制药跌7.78%、信达生物跌4.2%，百济神州作为权重龙头持续受到拖累。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640957252","title":"百济神州（688235）披露持股5%以上股东权益变动触及1%刻度的提示性公告，6月1日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640957252","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640957252?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:05","pubTimestamp":1780322737,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，百济神州报收于234.62元，较前一交易日下跌3.8%，最新总市值为3616.48亿元。该股当日开盘241.3元，最高248.88元，最低233.3元，成交额达12.42亿元，换手率为4.49%。近日，百济神州有限公司发布《关于持股5%以上股东权益变动触及1%刻度的提示性公告》。公告显示，公司持股5%以上股东Amgen Inc.因公司发行美国存托股份导致持股比例被动稀释，持股数量未变，仍为246,269,426股，持股比例由17.01%下降至16.70%，权益变动触及1%刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100040484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU1251922891.USD","LU1969619763.USD","BK1161","BK0239","06160","LU2328871848.SGD","LU1770034418.SGD","688235","BK1588","LU0307460666.USD","LU0588546209.SGD","LU1719994722.HKD","LU1303224171.USD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198958973","title":"异动解读｜百济神州盘中下跌3.11%，高层减持叠加创新药板块持续调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1198958973","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198958973?lang=zh_cn&edition=full","pubTime":"2026-06-01 11:11","pubTimestamp":1780283507,"startTime":"0","endTime":"0","summary":"6月1日，百济神州盘中下跌3.11%，报171.3港元/股，成交额3.57亿港元。消息面上，百济神州近期遭遇高层大额减持，贝克兄弟关联基金Baker Bros. Advisors LP减持约1.9亿美元，市场情绪承压。尽管机构仍保留董事会席位且合计持股比例约8.21%，但减持动作引发资金面担忧。此外，港股创新药板块自去年9月进入调整期至今已超8个月，板块标的指数区间跌幅超过30%，百济神州作为权重龙头持续受到拖累。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639644366","title":"百济神州安泰适在华获批用于小细胞肺癌二线治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2639644366","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639644366?lang=zh_cn&edition=full","pubTime":"2026-05-29 14:18","pubTimestamp":1780035480,"startTime":"0","endTime":"0","summary":"南方财经5月29日电，百济神州宣布，安泰适?（注射用塔拉妥单抗）获得国家药品监督管理局（NMPA）新增适应症批准，用于既往接受过1种系统性治疗（包括含铂化疗）失败的广泛期小细胞肺癌（ES-SCLC）成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605293754345695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0307460666.USD","LU0588546209.SGD","BK4526","BK4588","LU1969619763.USD","BK1161","LU1719994722.HKD","688235","LU1251922891.USD","ONC","LU1303224171.USD","06160","BK1500","BK1588","BK4139","BK0239","LU2328871848.SGD","BK1583","LU1770034418.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638196657","title":"本轮调整超8个月！港股通创新药继续磨底， 520880再创新低！康方生物、百济神州等权重龙头尽墨","url":"https://stock-news.laohu8.com/highlight/detail?id=2638196657","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638196657?lang=zh_cn&edition=full","pubTime":"2026-05-28 14:09","pubTimestamp":1779948540,"startTime":"0","endTime":"0","summary":"5月28日，港股深度调整，恒指一度跌逾2%。港股通创新药大幅走低，权重龙头集体飘绿，康方生物、百济神州跌逾2%，信达生物、中国生物制药跌超3%。　　100%创新药研发标的——港股通创新药ETF华宝午后下探3.68%，现跌2.99%，连续4日下行，场内价格再创上市以来新低。　　拉长时间看，港股通创新药自去年9月进入阶段调整期，至今已超8个月，港股通创新药ETF华宝标的指数区间跌幅已超过30%，当前位置或接近本轮调整底部区间，配置性价比凸显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-05-28/doc-inhzmpqs0236306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1794554557.SGD","LU2476274720.SGD","LU0588546209.SGD","LU0307460666.USD","BK1583","BK1161","06160","LU0561508036.HKD","BK4139","LU2328871848.SGD","IE00BPRC5H50.USD","LU0634319403.HKD","LU2488822045.USD","LU0417516571.SGD","LU1719994722.HKD","LU0348825331.USD","LU1251922891.USD","09926","BK1574","BK1588","LU1720050803.USD","LU0348766576.USD","LU1770034418.SGD","06978","IE00B5MMRT66.SGD","LU0348735423.USD","BK4585","LU0348827113.USD","LU1969619763.USD","BK4588","LU0348767384.USD","LU0417516902.SGD","688235","LU0540923850.HKD","LU2476274308.USD","BK0239","LU0348784397.USD","BK4526","IE00B543WZ88.USD","LU1961090484.USD","159992","VXUS","BK1500","LU1303224171.USD","LU0348783233.USD","LU0417516738.SGD","LU2399975544.HKD","LU2778985437.USD","ONC","520880"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1132736907","title":"异动解读｜百济神州盘中下跌3.21%，报175.0港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132736907","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132736907?lang=zh_cn&edition=full","pubTime":"2026-05-28 13:08","pubTimestamp":1779944912,"startTime":"0","endTime":"0","summary":"5月28日，百济神州盘中下跌3.21%，报175.0港元/股，成交额2.42亿港元。百济神州所在的生物科技行业中，个股中，信达生物跌2.6%，康方生物跌3.56%，三生制药跌6.54%，派格生物医药-B跌3.97%，荣昌生物跌4.01%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638630243","title":"上药控股与百济神州举行战略合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2638630243","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638630243?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:32","pubTimestamp":1779928320,"startTime":"0","endTime":"0","summary":"人民财讯5月28日电，据上药控股消息，5月27日下午，上药控股与百济神州举行战略合作签约仪式，双方在医药健康领域的深度合作由此迈入全新发展阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605283751977154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","LU1251922891.USD","ONC","LU1770034418.SGD","LU2328871848.SGD","BK1588","BK1500","688235","BK4526","LU0307460666.USD","LU1969619763.USD","BK1161","BK1583","LU0588546209.SGD","BK0239","06160","LU1303224171.USD","BK4139","BK4588","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159250896","title":"异动解读｜百济神州盘中下跌3.07%，报181.8港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159250896","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159250896?lang=zh_cn&edition=full","pubTime":"2026-05-27 09:40","pubTimestamp":1779846001,"startTime":"0","endTime":"0","summary":"5月27日，百济神州盘中下跌3.07%，报181.8港元/股，成交额1.44亿港元。百济神州所在的生物科技行业中，个股中，信达生物跌0.44%，康方生物涨1.16%，派格生物医药-B跌27.04%，三生制药涨0.71%，药捷安康-B涨5.22%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638585985","title":"中金：恒指季检调整后工业与医疗保健业覆盖度提升，6只股票或纳入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2638585985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638585985?lang=zh_cn&edition=full","pubTime":"2026-05-25 13:59","pubTimestamp":1779688785,"startTime":"0","endTime":"0","summary":"参照恒指公司的行业分类，此次恒指调整后，对于医疗保健业的覆盖度从38.8%提升至44.3%，对于工业的覆盖度从54.3%提升至56.0%。该行根据此次恒生综合指数调整情况、结合港股通纳入的额外要求，预计6只或符合港股通纳入范围。此次进入恒生综合指数的Minimax-W由于其同股不同权性质，需额外满足上市满6个月及20个交易日的条件，因此不会在本次6月调整中进入港股通，预计于8月纳入港股通。若后续满足市值与成交额要求，有望于8月纳入港股通。","market":"fut","thumbnail":"https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/38508134c6853c521e764dc952e7334a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7ab48a17674d5845193952fa54058c28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445467.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","HK0000286598.CNH","03033","02600","03067","07300","07552","LU0348735423.USD","LU0417516571.SGD","LU0417516902.SGD","83115","BK1513","LU1808992512.USD","02833","LU0348784397.USD","02828","LU2328871848.SGD","09088","02837","03419","IE00B543WZ88.USD","IE00B5MMRT66.SGD","601600","06160","07588","03692","09926","LU0348783233.USD","BK1500","82800","00100","07500","BK1151","LU1251922891.USD","03032","688235","BK1592","BK1583","LU0634319403.HKD","LU2476274308.USD","LU2488822045.USD","BK1588","HSTECH","LU0417516738.SGD","02800","LU0540923850.HKD","LU1969619763.USD","03088","LU0348766576.USD","01519","LU1961090484.USD","LU2778985437.USD","07288","513600","07226","03416","LU0348825331.USD","IE00BPRC5H50.USD","07200","MCHmain","02513","82828","03037","03423","LU1719994722.HKD","BK1568","BK1574","09067","LU1770034418.SGD","BK1175","ONC","HHImain","HSCEI","03115","LU0348767384.USD","LU2476274720.SGD","LU0307460666.USD","LU1794554557.SGD","BK1191","LU0561508036.HKD","BK1161","LU0348827113.USD","03417","LU1720050803.USD","LU1303224171.USD","LU2399975544.HKD","09115","BK1117","HSCI","HSI","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637399348","title":"智谱、MiniMax，有望加入恒生科技指数","url":"https://stock-news.laohu8.com/highlight/detail?id=2637399348","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637399348?lang=zh_cn&edition=full","pubTime":"2026-05-22 13:38","pubTimestamp":1779428280,"startTime":"0","endTime":"0","summary":"　　恒生指数公司将于今日收市后公布季度检讨结果。　　市场焦点集中在智谱、MiniMax这两只AI概念股，有望被纳入恒生科技指数及综合指数。　　根据市场分析，智谱、MiniMax因近期市值大幅上升，已成为纳入恒生科技指数的最有力候选。　　至于摩根士丹利此前预期，智谱、及MiniMax将于6月纳入恒生科技指数，合计权重约5%至7%，或带动12.5亿至17.5亿美元的被动资金流入，而纳入港股通可能会在6个月内将内地持股比例提升至自由流通股的9%至20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-05-22/doc-inhytyys6180072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02833","BK1574","09987","BK1583","01818","03417","LU0588546209.SGD","LU2476274720.SGD","09115","LU0310800379.SGD","LU2778985437.USD","LU0348766576.USD","BK1233","HSI","LU0417516571.SGD","07500","03037","LU1969619763.USD","LU2399975544.HKD","LU0823426308.USD","LU2476274308.USD","LU1720050803.USD","LU2279701549.SGD","BK1117","LU0348825331.USD","LU0348735423.USD","BK1544","03115","BK1500","LU0348783233.USD","82800","BK1592","06160","LU1770034418.SGD","BK1161","BK1198","LU0708994859.HKD","LU1719994722.HKD","LU0594300419.USD","IE00BPRC5H50.USD","LU0540923850.HKD","07552","00100","07200","513600","03419","09926","07300","03423","03033","07226","LU1251922891.USD","02513","03067","LU0348767384.USD","LU0561508036.HKD","83115","LU0650527681.SGD","HHImain","03032","LU0348827113.USD","IE0034224299.USD","BK1097","IE00B543WZ88.USD","LU2328871848.SGD","BK1588","BEKE","LU0348784397.USD","09088","03088","LU2488822045.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","YUMC","LU0307460666.USD","LU1303224171.USD","02800","LU0634319403.HKD","HSTECH","MHImain","ONC","LU0228659784.USD","LU1794554557.SGD","02837","02423","LU0417516902.SGD","LU1267930573.SGD","MCHmain","LU1961090484.USD","LU0128525929.USD","LU0029864427.USD","LU0823426480.USD","688235","09067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164258252","title":"异动解读｜百济神州盘中上涨3.48%，Q1业绩超预期叠加大行集体看涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1164258252","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164258252?lang=zh_cn&edition=full","pubTime":"2026-05-21 09:58","pubTimestamp":1779328699,"startTime":"0","endTime":"0","summary":"5月21日，百济神州盘中上涨3.48%，报185.2港元/股，成交额2.16亿港元。消息面上，公司Q1全球总收入15.13亿美元，同比增长35.5%，超出市场一致预期；GAAP净利润2.27亿美元，管理层将全年营收指引上调1亿美元至63亿至65亿美元。此外，新一代BCL2抑制剂百悦达获美国FDA加速批准，成为美国首款治疗复发或难治性套细胞淋巴瘤的BCL2抑制剂。花旗维持买入评级，美股目标价由430美元上调至453美元；中金维持跑赢行业评级，H股目标价250港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636140728","title":"百济神州美股盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636140728","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636140728?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:12","pubTimestamp":1779264777,"startTime":"0","endTime":"0","summary":"百济神州美股盘前涨超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743484856.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743484856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK1161","BK4585","LU1719994722.HKD","BK4139","BK1583","LU1251922891.USD","LU1969619763.USD","06160","BK1588","LU2328871848.SGD","BK1500","BK4588","LU0588546209.SGD","ONC","LU0307460666.USD","BK4526","LU1770034418.SGD","688235","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0781},{"period":"1month","weight":-0.1044},{"period":"3month","weight":-0.1059},{"period":"6month","weight":-0.1768},{"period":"1year","weight":0.0523},{"period":"ytd","weight":-0.0909}],"compareEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":-0.0478},{"period":"3month","weight":-0.0309},{"period":"6month","weight":-0.0431},{"period":"1year","weight":0.0441},{"period":"ytd","weight":-0.0261}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.059409},{"month":4,"riseRate":0.5,"avgChangeRate":0.034277},{"month":5,"riseRate":0.375,"avgChangeRate":-0.043816},{"month":6,"riseRate":0.375,"avgChangeRate":-0.003608},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}